Investors considering a purchase of Spyre Therapeutics Inc (Symbol ... Collecting that bid as the premium represents a 6.8% return against the $12.50 commitment, or a 13.5% annualized rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback